Please login to the form below

Not currently logged in
Email:
Password:

Flutiform

This page shows the latest Flutiform news and features for those working in and with pharma, biotech and healthcare.

Vectura's Flutiform flunks phase III COPD test

Vectura's Flutiform flunks phase III COPD test

Vectura's hopes of extending the uses of its asthma drug Flutiform into chronic obstructive pulmonary disease (COPD) have been dashed by disappointing phase III data. ... Flutiform sales doubled last year to reach 144m in 2015, and in the first six

Latest news

  • Vectura to merge with SkyePharma in £441m deal Vectura to merge with SkyePharma in £441m deal

    SkyePharma has just reported record revenues for 2015 of £95m, up 30% with the help of rising royalties and product supply fees for asthma therapy Flutiform (fluticasone/formoterol) and GlaxoSmithKline's

  • Successful partnerships in pharma: Skyepharma and Mundipharma Successful partnerships in pharma: Skyepharma and Mundipharma

    Why skills and flexibility matter more than sheer size. Skyepharma and Mundipharma collaborated on the respiratory drug Flutiform. ... was able to make decisions quickly and was equally committed to the success of Flutiform.

  • Double asthma approval in Japan lifts SkyePharma Double asthma approval in Japan lifts SkyePharma

    The Japanese Ministry of Health, Labour and Welfare (MHLW) cleared GlaxoSmithKline's (GSK) Relvar Ellipta (vilanterol and fluticasone), as well as Kyorin Pharmaceutical's Flutiform (formoterol and fluticasone) for the treatment ... Meanwhile, the

  • Portland Health wins Mundipharma account

    High on the Portland Health's agenda will be to raise the profile of the recently launched asthma drug Flutiform (fluticasone/formoterol).

  • Pharma news in brief

    Our weekly round-up of news affecting the industry. SkyePharma signs key Flutiform marketing deal. ... SkyePharma has finally signed a US marketing agreement for its key asthma treatment, Flutiform, with Kos Pharmaceuticals, a deal which could be worth

More from news
Approximately 2 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • Interview: Georg Toufar, Mundipharma Interview: Georg Toufar, Mundipharma

    Treatments successfully brought to market in this way include asthma treatment Flutiform, created by Skye Pharma, and restless legs syndrome treatment Targin.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics